Effect of Qiguiyin Decoction on multidrug-resistant Pseudomonas aeruginosa infection in rats.

Ling-bo Kong; Qun MA; Jie Gao; Guo-song Qiu; Li-xia Wang; Shu-min Zhao; Yong-gang Bao; Qing-quan Liu

Return

Effect of Qiguiyin Decoction on multidrug-resistant Pseudomonas aeruginosa infection in rats.

Author: Ling-Bo KONG ¹ ; Qun MA ² ; Jie GAO ¹ ; Guo-Song QIU ³ ; Li-Xia WANG ³ ; Shu-Min ZHAO ⁴ ; Yong-Gang BAO ⁴ ; Qing-Quan LIU ⁵
Author Information

1. Department of Emergency Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China.
2. School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
3. PepMetric Technologies Inc., Ottawa, Canada.
4. Beijing Genovax Biotech Corperation, Beijing, 100089, China.
5. Department of Emergency Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, 100700, China. Liuqingquan2003@126.com.
Publication Type:Journal Article
Keywords: Chinese medicine; Pseudomonas aeruginosa; Qiguiyin Decoction; multidrug-resistant; peptide array
MeSH: Animals; Antibodies, Bacterial; blood; Drug Resistance, Multiple, Bacterial; Drugs, Chinese Herbal; therapeutic use; Female; Interleukin-1beta; blood; Male; Pseudomonas Infections; drug therapy; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Th1 Cells; immunology; Th2 Cells; immunology; beta-Lactamases; immunology
From: Chinese journal of integrative medicine 2015;21(12):916-921
CountryChina
Language:English
Abstract:
OBJECTIVETo investigate the effect of Qiguiyin Decoction, QGYD) on multidrug-resistant Pseudomonas aeruginosa infection in Sprague-Dawley (SD) rats.
METHODSA pseudomonal infection model in SD rats was established by injecting multidrug-resistant P. aeruginosa intraperitoneally. Infected rats were randomized into four groups treated with Pure water, QGYD, ceftazidime, or combined QGYD and ceftazidime. Blood samples were obtained from the abdominal aorta. Serum was then collected and analyzed by peptide array for immune responsiveness to multidrug-resistant beta-lactamase proteins, including Verona integronen-coded metallo-beta-lactamase 1 (VIM-1), Sao Paulo metallo-beta-lactamase 1 (SPM-1), and Temoniera (TEMs). Blood levels of interleukin-1β (IL-1β), interleukin-4 (IL-4), and interferon-γ (IFN-γ) were assessed by enzyme-linked immunosorbent assay.
RESULTSQGYD enhanced antibody reactivity against VIM-1 [epitopes 7-11 and 36-40] and TEM-1 [epitopes 26-27, 52-55, and 66-70]. QGYD treatment restored the compromised antibody reactivity against VIM-1 [epitopes 53-54 and 56-58] and SPM-1 [epitopes 16-19 and 82-85] following pseudomonal infection. Serum levels of IL-1β and Th1/Th2 in the rats were significantly elevated following pseudomonal infection (P<0.05 orP<0.01). In contrast, QGYD and combination QGYD and ceftazidime treatment restored the elevated serum IL-1β and Th1/Th2 levels to normal (P>0.05).
CONCLUSIONSQGYD improves the immune response to pseudomonal infection in rats by stimulating the production of protective antibodies against drug-resistant proteins VIM-1, SPM-1, and TEM-1. In addition, it protects the immune system and maintains immune responsiveness by restoring IL-1β and Th1/Th2 levels.